Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07546539 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Photobiomodulation in Chronic Fatigue Syndrome

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Jul 15, 2026 → Dec 15, 2026
See other at-risk trials from University of Lahore

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 15, 2026 to Dec 15, 2026
    • Study completion pushed from Sep 2026 to Feb 2027
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 6 of 8 entries
  2. Recruitment openedv5
  3. Start date: Apr 15, 2026 to Jun 15, 2026v4
  4. Eligibility criteria expanded, about 1 wordv3
  5. Secondary endpoints: details revised at 8 of 8 entries
    • Eligibility criteria expanded, about 4 words
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to evaluate whether photobiomodulation therapy (low-level laser therapy) can reduce fatigue and improve quality of life in patients with chronic fatigue syndrome (CFS). The study will include adults aged 18-60 years diagnosed with chronic fatigue syndrome. The main questions it aims to answer are: Does photobiomodulation therapy significantly reduce fatigue levels as measured by the Fatigue Severity Scale (FSS) and Multidimensional Fatigue Inventory (MFI-20)? Does photobiomodulation therapy improve pain, functional capacity, sleep quality, and psychological well-being in patients with chronic fatigue syndrome? Researchers will compare the low-level laser therapy group with a placebo (sham laser) group to determine whether photobiomodulation therapy leads to greater improvements in fatigue, pain, and overall quality of life. Participants will: Receive either active low-level laser therapy or placebo treatment three times per week for eight weeks Undergo assessments of fatigue, pain, functional capacity, quality of life, sleep quality, and psychological well-being at baseline and follow-up intervals (3, 6, and 12 months)
Trial Details
NCT Number NCT07546539
Lead Sponsor University of Lahore
Conditions
(from sponsor)		 Chronic Fatigue Syndrome (CFS), Quality of Life
Related terms Fatigue, Fatigue Syndrome, Chronic
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov